Justin Nathaniel Karlin

Justin Karlin practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Justin Karlin's NPI, 1427476464, was assigned on April 6, 2014. Justin Karlin graduated from Tel Aviv University Sackler in 2014. Justin Karlin holds California license A152656.

Justin Karlin's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Justin Karlin's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Justin Karlin is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Justin Karlin to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Justin Karlin practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Justin Karlin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Justin Karlin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Justin Karlin's licenses on file in 2 states: California and Virginia.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, inflammation of iris, scleritis, shingles and vision problems among the conditions Justin Karlin treats.

CMS data shows 6,008 Medicare services from Justin Karlin across 15 procedure codes in 2024, for 522 Medicare patients. Medicare paid $140,966 for them.

CMS counts 522 Medicare patients who saw Justin Karlin in 2024. The largest group is 65 to 74, with 217 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Justin Karlin's median patient age at 69, with 60% women.

In 2024, Justin Karlin wrote 329 Medicare Part D claims for 194 patients. 72% of them were for generic drugs. CMS names the drug for 225 of them, across 4 drugs with 11 or more claims each, at $16,224 in total drug cost. In 2023, CMS named 171 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Justin Karlin for performance year 2024, reported as part of a group. Justin Karlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Justin Karlin as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Justin Karlin, published from 2011 to 2021. Justin Karlin's most frequent co-author is Maria Kirzhner, MD.

CMS Open Payments shows 100 general payments to Justin Karlin from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Horizon Pharma plc paid the most, $10,288.

Justin Karlin graduated from Tel Aviv University Sackler in 2014.

Justin Karlin is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.